SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹31 Cr | ₹27 Cr | ₹23 Cr | ₹14 Cr | ₹11 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹31 Cr |
| Mar2025 | ₹27 Cr |
| Mar2024 | ₹23 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹11 Cr |
How is Deferred Tax Assets / Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹31 Cr | 15.64 | |
| Mar2025 | ₹27 Cr | 16.70 | |
| Mar2024 | ₹23 Cr | 69.30 | |
| Mar2023 | ₹14 Cr | 22.66 | |
| Mar2022 | ₹11 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,884.4 Cr | 7% | -4% | 27.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 7% |
-4% |
27.1% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses